Your browser doesn't support javascript.
loading
Profiling the immune landscape in mucinous ovarian carcinoma.
Meagher, Nicola S; Hamilton, Phineas; Milne, Katy; Thornton, Shelby; Harris, Bronwyn; Weir, Ashley; Alsop, Jennifer; Bisinoto, Christiani; Brenton, James D; Brooks-Wilson, Angela; Chiu, Derek S; Cushing-Haugen, Kara L; Fereday, Sian; Garsed, Dale W; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Gilks, Blake; Jimenez-Linan, Mercedes; Kennedy, Catherine J; Le, Nhu D; Piskorz, Anna M; Riggan, Marjorie J; Shah, Mitul; Singh, Naveena; Talhouk, Aline; Widschwendter, Martin; Bowtell, David D L; Candido Dos Reis, Francisco J; Cook, Linda S; Fortner, Renée T; García, María J; Harris, Holly R; Huntsman, David G; Karnezis, Anthony N; Köbel, Martin; Menon, Usha; Pharoah, Paul D P; Doherty, Jennifer A; Anglesio, Michael S; Pike, Malcolm C; Pearce, Celeste Leigh; Friedlander, Michael L; DeFazio, Anna; Nelson, Brad H; Ramus, Susan J.
  • Meagher NS; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia; The Daffodil Centre, The University of Sydney, A Joint Venture with Ca
  • Hamilton P; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada.
  • Milne K; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada.
  • Thornton S; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada.
  • Harris B; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada.
  • Weir A; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Bisinoto C; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Chiu DS; British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada.
  • Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Gentry-Maharaj A; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Gilks B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Jimenez-Linan M; Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
  • Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia.
  • Le ND; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
  • Piskorz AM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Riggan MJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA.
  • Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Singh N; Department of Pathology, Barts Health National Health Service Trust, London, UK; Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, Canada.
  • Talhouk A; British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Obstetrics and Gynec
  • Widschwendter M; EUTOPS Institute, University of Innsbruck, Innsbruck, Austria.
  • Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Candido Dos Reis FJ; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Cook LS; Epidemiology, School of Public Health, University of Colorado, Aurora, CO, USA; Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • García MJ; Computational Oncology Group, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Huntsman DG; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
  • Karnezis AN; Department of Pathology and Laboratory Medicine, UC Davis Medical Center, Sacramento, CA, USA.
  • Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
  • Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Doherty JA; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
  • Anglesio MS; British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Pike MC; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Friedlander ML; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia; Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, New South Wales, Aust
  • DeFazio A; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council New South Wales, Australia; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wale
  • Nelson BH; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada.
  • Ramus SJ; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia. Electronic address: s.ramus@unsw.edu.au.
Gynecol Oncol ; 168: 23-31, 2023 01.
Article en En | MEDLINE | ID: mdl-36368129
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article